Literature DB >> 31940011

Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial.

David J Miklowitz1, Christopher D Schneck2, Patricia D Walshaw1, Manpreet K Singh3, Aimee E Sullivan2, Robert L Suddath1, Marcy Forgey Borlik1, Catherine A Sugar1,4, Kiki D Chang5.   

Abstract

Importance: Behavioral high-risk phenotypes predict the onset of bipolar disorder among youths who have parents with bipolar disorder. Few studies have examined whether early intervention delays new mood episodes in high-risk youths. Objective: To determine whether family-focused therapy (FFT) for high-risk youths is more effective than standard psychoeducation in hastening recovery and delaying emergence of mood episodes during the 1 to 4 years after an active period of mood symptoms. Design, Settings, and Participants: This multisite randomized clinical trial included referred youths (aged 9-17 years) with major depressive disorder or unspecified (subthreshold) bipolar disorder, active mood symptoms, and at least 1 first- or second-degree relative with bipolar disorder I or II. Recruitment started from October 6, 2011, and ended on September 15, 2016. Independent evaluators interviewed participants every 4 to 6 months to measure symptoms for up to 4 years. Data analysis was performed from March 13 to November 3, 2019. Interventions: High-risk youths and parents were randomly allocated to FFT (12 sessions in 4 months of psychoeducation, communication training, and problem-solving skills training; n = 61) or enhanced care (6 sessions in 4 months of family and individual psychoeducation; n = 66). Youths could receive medication management in either condition. Main Outcomes and Measures: The coprimary outcomes, derived using weekly psychiatric status ratings, were time to recovery from prerandomization symptoms and time to a prospectively observed mood (depressive, manic, or hypomanic) episode after recovery. Secondary outcomes were time to conversion to bipolar disorder I or II and longitudinal symptom trajectories.
Results: All 127 participants (82 [64.6%] female; mean [SD] age, 13.2 [2.6] years) were followed up for a median of 98 weeks (range, 0-255 weeks). No differences were detected between treatments in time to recovery from pretreatment symptoms. High-risk youths in the FFT group had longer intervals from recovery to the emergence of the next mood episode (χ2 = 5.44; P = .02; hazard ratio, 0.55; 95% CI, 0.48-0.92;), and from randomization to the next mood episode (χ2 = 4.44; P = .03; hazard ratio, 0.59; 95% CI, 0.35-0.97) than youths in enhanced care. Specifically, FFT was associated with longer intervals to depressive episodes (log-rank χ2 = 6.24; P = .01; hazard ratio, 0.53; 95% CI, 0.31-0.88) but did not differ from enhanced care in time to manic or hypomanic episodes, conversions to bipolar disorder, or symptom trajectories. Conclusions and Relevance: Family skills-training for youths at high risk for bipolar disorder is associated with longer times between mood episodes. Clarifying the relationship between changes in family functioning and changes in the course of high-risk syndromes merits future investigation. Trial Registration: ClinicalTrials.gov identifier: NCT01483391.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31940011      PMCID: PMC6990706          DOI: 10.1001/jamapsychiatry.2019.4520

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  44 in total

1.  Phenomenology of children and adolescents with bipolar spectrum disorders.

Authors:  David Axelson; Boris Birmaher; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Jeffrey Bridge; Martin Keller
Journal:  Arch Gen Psychiatry       Date:  2006-10

2.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

3.  Randomized trial comparing caregiver-only family-focused treatment to standard health education on the 6-month outcome of bipolar disorder.

Authors:  Deborah A Perlick; Carlos Jackson; Savannah Grier; Brittney Huntington; Andrew Aronson; Xiaodong Luo; David J Miklowitz
Journal:  Bipolar Disord       Date:  2018-03-12       Impact factor: 6.744

4.  Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.

Authors:  David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Stephen R Wisniewski; Jane N Kogan; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Laszlo Gyulai; Mako Araga; Jodi M Gonzalez; Edwin R Shirley; Michael E Thase; Gary S Sachs
Journal:  Arch Gen Psychiatry       Date:  2007-04

5.  Bipolar disorder and family communication: effects of a psychoeducational treatment program.

Authors:  T L Simoneau; D J Miklowitz; J A Richards; R Saleem; E L George
Journal:  J Abnorm Psychol       Date:  1999-11

6.  A Risk Calculator to Predict the Individual Risk of Conversion From Subthreshold Bipolar Symptoms to Bipolar Disorder I or II in Youth.

Authors:  Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-08-07       Impact factor: 8.829

7.  A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children mania rating scale for children and adolescents.

Authors:  David Axelson; Boris J Birmaher; David Brent; Susan Wassick; Christine Hoover; Jeffrey Bridge; Neal Ryan
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

Review 8.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 9.  An evidence map of psychosocial interventions for the earliest stages of bipolar disorder.

Authors:  Martine Vallarino; Chantal Henry; Bruno Etain; Lillian J Gehue; Craig Macneil; Elizabeth M Scott; Angelo Barbato; Philippe Conus; Stefanie A Hlastala; Mary Fristad; David J Miklowitz; Jan Scott
Journal:  Lancet Psychiatry       Date:  2015-05-27       Impact factor: 27.083

10.  Family-focused therapy for individuals at clinical high risk for psychosis: treatment fidelity within a multisite randomized trial.

Authors:  Sarah E Marvin; David J Miklowitz; Mary P O'Brien; Tyrone D Cannon
Journal:  Early Interv Psychiatry       Date:  2014-04-11       Impact factor: 2.732

View more
  20 in total

1.  Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Filippo Posta; John A Merranko; Manpreet K Singh; Kiki D Chang; David J Miklowitz
Journal:  J Consult Clin Psychol       Date:  2022-01-27

2.  Longitudinal relationship between maternal distress and pediatric mood symptoms in youth with mood disorders.

Authors:  Marc J Weintraub; Christopher D Schneck; Manpreet K Singh; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; David J Miklowitz
Journal:  J Psychiatr Res       Date:  2021-10-26       Impact factor: 4.791

3.  Longitudinal trajectories of mood symptoms and global functioning in youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; Manpreet K Singh; David J Miklowitz
Journal:  J Affect Disord       Date:  2020-08-13       Impact factor: 4.839

4.  Isn't the evidence base for pediatric bipolar disorder already sufficient to inform clinical practice?

Authors:  Manpreet K Singh; Kiki D Chang; Benjamin I Goldstein; David J Miklowitz; Cesar Soutullo; Eric Youngstrom; Boris Birmaher; David Axelson; Robert M Post; Melissa P DelBello
Journal:  Bipolar Disord       Date:  2020-09-09       Impact factor: 6.744

5.  Social impairment in relation to clinical symptoms in youth at high risk for bipolar disorder.

Authors:  Marc J Weintraub; Danielle Keenan-Miller; Christopher D Schneck; Marcy Forgey Borlik; Robert L Suddath; Sarah E Marvin; Manpreet K Singh; Kiki D Chang; David J Miklowitz
Journal:  Early Interv Psychiatry       Date:  2021-02-08       Impact factor: 2.732

6.  Using machine learning analyses of speech to classify levels of expressed emotion in parents of youth with mood disorders.

Authors:  Marc J Weintraub; Filippo Posta; Armen C Arevian; David J Miklowitz
Journal:  J Psychiatr Res       Date:  2021-01-28       Impact factor: 4.791

7.  Moody kids years later: Long-term outcomes of youth from the Omega-3 and therapy (OATS) studies.

Authors:  Mary A Fristad; Michelle E Roley-Roberts; Sarah R Black; L Eugene Arnold
Journal:  J Affect Disord       Date:  2020-11-27       Impact factor: 4.839

8.  Therapeutic alliance in family therapy and clinical outcomes among adolescents at risk for mood disorders.

Authors:  Nicole R Wong; Kayla E Carta; Marc J Weintraub; David J Miklowitz
Journal:  J Affect Disord       Date:  2021-12-22       Impact factor: 4.839

9.  Development and Open Trial of a Technology-Enhanced Family Intervention for Adolescents at Risk for Mood Disorders.

Authors:  David J Miklowitz; Marc J Weintraub; Filippo Posta; Patricia D Walshaw; Samantha J Frey; Georga M Morgan-Fleming; Catherine A Wilkerson; Danielle M Denenny; Armen A Arevian
Journal:  J Affect Disord       Date:  2020-12-08       Impact factor: 4.839

10.  Changes in Intrinsic Brain Connectivity in Family-Focused Therapy Versus Standard Psychoeducation Among Youths at High Risk for Bipolar Disorder.

Authors:  Manpreet K Singh; Akua F Nimarko; Amy S Garrett; Aaron J Gorelik; Donna J Roybal; Patricia D Walshaw; Kiki D Chang; David J Miklowitz
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-08-01       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.